Ocugen OCGN
NASDAQ OCGN
$1.36 +0.01 (+0.74%)
At close: Sep 4, 2026 · 4:00 PM EDT

Ocugen (OCGN) Other Accumulated Expenses (2015 - 2020)

Ocugen's (OCGN) quarterly Other Accumulated Expenses came in at $9755.0 in Q4 2020, down 95.26% YoY from $205991.0 in Q1 2020, and down 95.1% on a QoQ basis from $199261.0 in Q3 2020.

Analysis

Ocugen (OCGN) Other Accumulated Expenses (2015 - 2020) Analysis & Trends

Ocugen (OCGN) has 6 years of Other Accumulated Expenses data on file, last reported at $9755.0 in Q4 2020.

  • Quarterly Other Accumulated Expenses fell 95.26% year-over-year to $9755.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $9755.0 (down 95.26% YoY) and the FY2020 annual result came in at $9755.0, down 95.26% from the prior year.
  • Other Accumulated Expenses slipped to $9755.0 in Q4 2020, from $199261.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $632000.0 in Q4 2017 to a low of $9755.0 in Q4 2020.
  • A 5-year average of $271315.5 and a median of $205425.5 in 2019 frame the typical range for Other Accumulated Expenses.
  • Annual changes were most pronounced in 2017 — Other Accumulated Expenses grew 24.41% — and 2020, when it sank 95.26%.
  • Tracing OCGN's Other Accumulated Expenses over 5 years: stood at $508000.0 in 2016, then gained by 24.41% to $632000.0 in 2017, then tumbled by 67.68% to $204242.0 in 2018, then increased by 0.86% to $205991.0 in 2019, then slumped by 95.26% to $9755.0 in 2020.
  • The last three Other Accumulated Expenses figures came in at $9755.0 (Q4 2020), $199261.0 (Q3 2020), and $204860.0 (Q2 2020), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Ocugen 458.91 Mn 358.81 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 9,755.00
Sep 30, 2020 199,261.00
Jun 30, 2020 204,860.00
Mar 31, 2020 206,415.00
Dec 31, 2019 205,991.00
Dec 31, 2018 204,242.00
Dec 31, 2017 632,000.00
Dec 31, 2016 508,000.00
Dec 31, 2015 548,000.00